moneycontrol.com14d
Stocks to Watch Today: Wipro, Tech Mahindra, Kotak Bank, RBL Bank, Gland Pharma, Zydus Life, Ashapura Minechem, Laxmi Dental in focus on 20 January
Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and acquisitions, here’s a quick look at which stocks will be ...
Indiatimes18d
ITC, Zydus and FMCG giants can't ignore this booming part of India if they want to win
The trend is also visible in other FMCG companies. Zydus Wellness, the company behind brands like Complan and Glucon-D, is expanding its rural coverage, focusing on increasing penetration where brands ...
ndtvprofit24d
Zydus Lifesciences Gets Nomura's 'Buy' Upgrade On Earnings Growth, Currency Movement
Nomura has upgraded Zydus Lifesciences Ltd. to a 'buy' from its earlier 'neutral' stance, raising the target price to Rs 1,140 from Rs 1,030, implying a potential upside of 16%. Robust earnings growth ...
cnbctv1825d
Zydus Life's US revenue may fall 5% in FY26 but Nomura sees a 15% upside
Brokerage firm Nomura has upgraded shares of Zydus Lifesciences Ltd. to "buy" from its earlier rating of "hold" and also raised its price target to ₹1,140 from ₹1,030 earlier. In a note on Thursday, ...
Indiatimes27d
Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formulary
Zydus Pharmaceuticals USA Inc President & CEO Punit Patel said the relationship is a strong validation of Zydus' strategic investments in the new drug applications portfolio. It "will set the way for ...
Business Standard27d
Zydus partners with CVS Caremark
CVS Caremark will add Zydus' Zituvio™ and combination products to its template formulary Zydus Lifesciences (including its subsidiaries/affiliates, hereafter ...